Therapeutic Areas COVID-19

CTI and COVID-19

If your program has been impacted by COVID-19

We know that nearly everyone around the world is dealing with some kind of impact from this pandemic. Our international teams have been meeting constantly over the past several weeks to devise plans and strategies to overcome the challenges presented to us by this situation. Some of the ways we can help you navigate these challenges include:
  • Writing necessary protocol amendments due to changes or limitations in patient follow up and procedures
  • Acting as a liaison with regulatory agencies to discuss next steps for trials delaying or ending enrollment
  • Conducting Interim Analysis or developing Clinical Study Reports if a program is delayed due to a halt in enrollment
  • Performing remote Pre-Study Visits, Feasibility and Monitoring Visits
  • Collaborating with sponsors and vendors to have products shipped directly to research patients
  • Guiding and supporting clinical research staff at sites and sponsors
  • Assessing the economic impact of COVID-19 on clinical programs 

If you are actively planning a program to address COVID-19

CTI has a wealth of experience in rare diseasesinfectious diseases, and current ongoing COVID-19 programs. Below are some examples of how we can help as you prepare your program to fight COVID-19: 
  • Submit FDA/EMA/Regulatory submissions - expanded indications for products to treat or prevent COVID-19
  • Use our extensive database of sites and patients to expedite study start up and enrollment for global expanded access programs and clinical programs
  • Manage expanded access programs to utilize products to treat or prevent COVID-19
  • Develop and manage any new US or global clinical trial for prevention or treatment of COVID-19
  • Create Database/EMR analysis of specific regions with COVID-19 
  • Perform epidemiologic assessments of COVID-19-affected populations

Vaccine Experience and COVID-19 Site

CTI’s Clinical Research Center (CTI CRC) is a vaccine-experienced clinical research unit in Cincinnati, OH that has been conducting clinical trials for more than 20 years, and has completed over 900 trials across all phases of development.  The team has contributed to multiple vaccine trials, including work in pandemic environments during the H1N1 (swine flu) outbreak, where the team conducted two Phase II trials and enrolled over 100 subjects in ~24 hours, and the H5N1 (bird flu) outbreak, where the Phase I trial went through an FDA audit with no 483s issued to the site. Additionally, the unit has collaborated with large pharmaceutical companies and emerging biopharmaceutical companies as part of trials resulting in vaccine approvals in areas including HPV, influenza, meningococcal group B, shingles and swine flu. The CRC has completed 15 recent vaccine trials with a 92% subject retention rate.

Our industry is in a unique position to substantially alter the future if we work together effectively. CTI is actively working on solutions to help our world as it fights COVID-19. 

If you would like to help CTI care for the community

CTI is doing everything we can to help our communities during this pandemic. If you would like to join us, below are some ways you can help:
  • Work with Gravity Diagnostics - CTI has been working with a local laboratory in Covington, KY, Gravity Diagnostics, to support their development of COVID-19 testing, from helping them source supplies to lending direct assistance from members of our staff. If you have any kind of lab experience and would like to help Gravity Diagnostics in the processing of tests and future development, please fill out this form and indicate your interest in working with Gravity Diagnostics.
  • Donate to the NKY Coronavirus Emergency fund - CTI has already contributed to the fund to address the most pressing needs of the Northern Kentucky community during this unprecedented pandemic. We strongly encourage our partners in the Cincinnati/NKY area to do the same. If you are based elsewhere, we would ask you to check with your local resources to see how you can help in a similar way.
  • Help feed students in need - CTI is supporting the Covington, KY school district provide food to the students who rely on school meals for their daily nourishment. You can support our local students as well by donating here. Or, if you are based outside of Cincinnati, reach out to your local school district to see what programs they have in place. 

CTI cares for its people, and we encourage other organizations to do the same

We've never seen anything like COVID-19 before, but we've experienced recessions, policy changes, revolutions in technology, shortages in the workforce, and many other challenges over the past 20+ years. CTI has always prevailed because supporting our employees has always been a top priority. Below are some of the ways we are prioritizing our team members during this pandemic:
  • Prioritizing safety - We instituted a global work-from-home policy and suspended all travel, whether a local government has required it or not.
  • Offering flexibility - We have made sure our team knows we understand the family challenges they may be experiencing and have offered flexibility to their traditional work schedules.
  • Ensuring stability and security - CTI has had zero layoffs in 20+ years. We immediately communicated to our employees that we do not intend to break with this policy. We are also guaranteeing full pay and offering financial assistance to employees in need.
We highly encourage our partners to adopt similar policies, and to put their people first. The world is relying on the pharma and biotech communities to develop the light at the end of the tunnel, and we cannot do so without the dedication and hard work of our amazing teams.

Stay well. Stay safe. Stay strong. We will get through this together.

Research Site or Hospital Interested in a COVID-19 Study?

Icon Contact Small Retina


CTI is actively working with many partners in the industry on current and upcoming COVID-19 programs. We are actively looking for sites in the US and globally willing to participate in these upcoming efforts. Please email

Participate in a Future COVID-19 Study


In order for a drug or vaccine to be approved for the general public, research studies need healthy individuals willing to participate in trials to test these new medications. If you are interested in participating in a future COVID-19 trial at our Clinical Research Center, please click the link below.

I'm Interested in COVID-19 Trials

CTI COVID-19 News and Press

Icon Therapeutics Small Retina


Stay up-to-date on the latest news and press invloving CTI's work in COVID-19

Click Here